Instrument Inactif

Communiqués NattoPharma ASA

Actions

NATTO

NO0010289200

Produits pharmaceutiques

Communiqués

25/06/21	NattoPharma ASA : - Delisting	AQ
15/06/21	NattoPharma : Received application for delisting	AQ
14/06/21	NattoPharma : Annual General Meeting in NattoPharma ASA	AQ
10/06/21	NattoPharma : OSLO BØRS - SUSPENDED	AQ
09/06/21	NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition	AQ
19/05/21	NattoPharma ASA: Results of mandatory offer for all outstanding shares in NattoPharma ASA	AQ
18/05/21	NattoPharma ASA: End of Offer Period for mandatory offer for all outstanding shares in NattoPharma ASA	AQ
18/05/21	NattoPharma ASA: 90% threshold surpassed	AQ
12/05/21	NattoPharma : releases Q1 2021 Trading Update	AQ
20/04/21	NattoPharma ASA: Lesaffre is launching mandatory offer for NattoPharma	AQ
19/04/21	NattoPharma : Mandatory offer - offer document approved	AQ
12/04/21	NattoPharma ASA: Compagnie des Levures Lesaffre completes settlement of option shares	AQ
08/04/21	NattoPharma : Financial calendar	AQ
29/03/21	NattoPharma : MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDERS AND CLOSE ASSOCIATES	AQ
29/03/21	NattoPharma : Disclosure of large shareholding	AQ
29/03/21	NattoPharma ASA: Compagnie des Levures Lesaffre completes voluntary offer for all outstanding shares in NattoPharma ASA	AQ
29/03/21	NattoPharma : New share capital registered	AQ
24/03/21	NattoPharma ASA: Final results of voluntary offer for all outstanding shares in NattoPharma ASA	AQ
23/03/21	NattoPharma : Update on acceptances - cash tender offer for all outstanding shares in Kaydence Pharma AS.	AQ
23/03/21	NattoPharma ASA: Preliminary results of voluntary offer for all outstanding shares in NattoPharma ASA and fulfilment of closing conditions	AQ
23/03/21	NattoPharma ASA: End of Offer Period for voluntary offer for all outstanding shares in NattoPharma ASA	AQ
09/03/21	NattoPharma ASA : is launching cash tender offer to acquire 100% of the shares of Kaydence Pharma AS at an offer price of NOK 5 per share	AQ
09/03/21	NattoPharma ASA: Lesaffre is launching recommended voluntary cash offer for NattoPharma at NOK 35 per share	AQ
08/03/21	NattoPharma : Voluntary offer - offer document approved	AQ
02/03/21	NattoPharma : Contemplated voluntary cash offer by Lesaffre to acquire all shares in NattoPharma	AQ